The Natera class action lawsuit over allegedly misleading prenatal test marketing has reached a proposed $8.25 million settlement, and people in the United States who paid out-of-pocket for a Panorama or Vasistera screening during set date ranges can file a claim by July 24, 2026. The case, In re Natera Prenatal Testing Litigation, is pending final approval from Judge Jon S. Tigar in the U.S. District Court for the Northern District of California, with a fairness hearing set for August 20, 2026.1ClassAction.org. $8.25M Natera Settlement Ends Class Action Lawsuit Over Allegedly Inaccurate Prenatal Testing
What the Lawsuit Alleged
Natera markets noninvasive prenatal tests under the Panorama and Vasistera brand names. The tests analyze fetal DNA in a pregnant person’s blood to flag elevated risk for chromosomal conditions like Down syndrome, trisomy 18, and trisomy 13. The consumer class action, filed February 17, 2022, alleged that Natera promoted these tests as broadly reliable while concealing much weaker performance on rarer conditions.2CourtListener. In Re Natera Prenatal Testing
Natera’s brochure advertised “fewer false positives and fewer false negatives,” and its website described Panorama as “the most reliable way of non-invasively assessing a baby’s health.” The company featured a positive predictive value above 90% for Down syndrome. But according to the complaint, Natera failed to disclose how much less accurate the tests were for rare microdeletions. A 2016 study Natera itself acknowledged found a positive predictive value of just 18% for DiGeorge syndrome, meaning 82% of positive results were false. For some other rare conditions, PPVs dropped as low as 2% to 5%.3FindLaw. In Re Natera Prenatal Testing Litigation
A January 2022 New York Times investigation put similar numbers on the record: 81% of positive results for DiGeorge syndrome, 93% for Prader-Willi and Angelman syndromes, and 86% for Wolf-Hirschhorn syndrome were incorrect. The complaint alleged these false positives pushed some expectant parents into expensive invasive follow-up procedures like amniocentesis and caused severe anxiety, and the Times reported that some women terminated viable pregnancies based on inaccurate results.4The New York Times. Pregnancy Birth Genetic Testing
Natera denies the allegations. The company has said its tests are “highly reliable and accurate,” supported by nearly 50 peer-reviewed publications, and that its marketing was neither misleading nor confusing.5ClassAction.org. In Re Natera Prenatal Testing Litigation Settlement Agreement
Who Qualifies for the Settlement
The settlement class covers anyone in the United States who paid out-of-pocket costs — copays, co-insurance, or deductibles — for a Natera Panorama or Vasistera screening during a state-specific window. All windows end August 7, 2025. If insurance or another third party paid the full cost of your test, you are not in the class.6Natera NIPT Settlement. In Re Natera Prenatal Testing Litigation Settlement
The start dates by state:
- Ohio: February 17, 2016
- New Jersey: May 5, 2016
- Florida: February 24, 2017
- New York and Illinois: April 27, 2017
- All other states: February 17, 2018
How Much You Can Receive
Eligible class members who file a valid claim receive a flat $30 payment with no proof of purchase required. Claimants who can document out-of-pocket costs above $300 may instead choose to receive up to 10% of what they paid. Both amounts are subject to pro-rata adjustment depending on how many claims come in and what remains after attorneys’ fees, litigation costs, and service awards are deducted from the fund.7ClassAction.org. In Re Natera Prenatal Testing Litigation Notice
Class counsel may seek up to 30% of the $8.25 million fund in fees, up to $300,000 in litigation costs, and service awards of up to $10,000 for each class representative. Payments will be made by check or electronic transfer.7ClassAction.org. In Re Natera Prenatal Testing Litigation Notice
The settlement also includes a non-monetary term: Natera agreed to add language to its Panorama webpage stating that the test “does NOT tell with certainty if a fetus is affected” and that high-risk results require diagnostic confirmation from a healthcare provider.5ClassAction.org. In Re Natera Prenatal Testing Litigation Settlement Agreement
How to File a Claim
Claims can be submitted online at NateraNIPTSettlement.com or by mailing a printed claim form to the settlement administrator. The deadline to file, opt out, or object is July 24, 2026. If you received a mailed or emailed notice, use the unique ID and PIN on it to file online. If you believe you qualify but never received a notice, contact the administrator through the site’s contact page.8Natera NIPT Settlement. In Re Natera Prenatal Testing Settlement Dates9Natera NIPT Settlement. In Re Natera Prenatal Testing Settlement FAQ
The settlement administrator’s contact information:
- Phone: 1-844-496-0872
- Email: info@NateraNIPTSettlement.com
- Mail: P.O. Box 25226, Santa Ana, CA 92799
When Payments Will Go Out
No money will be distributed until the court grants final approval and any appeals are resolved. The final fairness hearing is scheduled for August 20, 2026. Filing early does not speed up payment; it only secures your place in the class.9Natera NIPT Settlement. In Re Natera Prenatal Testing Settlement FAQ
Other Natera Cases This Settlement Does Not Cover
Two separate lawsuits against Natera are often confused with the accuracy settlement. Neither pays out through the $8.25 million fund.
The first is a billing class action, now captioned Calcaterra v. Natera, Inc. (Case No. 4:23-cv-06342-YGR, N.D. Cal.), alleging that Natera promised out-of-pocket costs would not exceed $249 but billed patients hundreds or thousands of dollars more. Named plaintiff Elizabeth Copley said she was billed $721.10 after being told the test would cost no more than $250; Rachel Calcaterra was billed $10,505 for a Horizon test and $8,000 for a Panorama test. That case covers Panorama, Horizon, Vistara, and Spectrum tests, and it was in discovery as of late 2023.10ClassAction.org. Class Action Alleges Customers Received Surprise Bills for Natera Genetic Tests11Wolf Popper LLP. Natera, Inc. Consumer Litigation
The second is a securities fraud action brought by investors, Schneider v. Natera, Inc. (Case No. 1:22-cv-00398, W.D. Tex.), covering a class period from February 26, 2020, through March 14, 2022. That case is for shareholders who bought Natera stock, not for patients who took the tests. Plaintiffs won class certification in spring 2025, and fact discovery is ongoing as of mid-2026.12Kessler Topaz Meltzer Check LLP. Natera, Inc.
If your issue with Natera was a surprise bill rather than the accuracy of results, the billing case is the one to watch; the accuracy settlement will not compensate you for overbilling.